1 Lee H.Y., Park H.C., Seo B.J., Do J.Y., Yun S.R., Song H.Y., Kim Y.H., Kim Y.L., Kim Y.S., Ahn C., Kim M.J. i Shin S.K. Superior patient survival for continous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation concentration (balance). Peritoneal Dialysis International 2005; 25(3):248-255.
2Lee Y.L., Choi H.Y., Park H.C., Seo B.J., Do J.Y., Yun S.R., Song H.Y., Kim Y.H., Kim Y.L., Kim D.J., Kim Y.S., Kim M.J. i Shin S.K. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrology Dialysis Transplantation 2006;21:2893-2899.
3 Dunst R., Alscher D.M., Knödler P., Pfinder-Nohe E., Tast C., Kuhlmann U. i Mettang T. Peritonitis rates using different CAPD systems. Peritoneal Dialysis International 2001;21(Suppl.2):S65
4 Van Biesen W., Kirchgessner J., Schilling H., Lage C., Lambert M.C., Passilick-Deetjen J. stay•safe®, a new PVC-free system for PD: Results of the multicenter trial. Peritoneal Dialysis International 1999;19(Suppl.1):S43.
5 Lambert M.C., Lage C., Kirchgessner J. stay•safe®, a new PVC-free system in long-term CAPD treatment. European Dialysis and Transplant Nurses Association/European Renal Care Association Journal 1999;25(3):30-34.
6 Issad B., Taamma R., Allouache M., Deray G. stay•safe®, a new PVC-free system for CAPD: Results of a multicenter survey. Peritoneal Dialysis International 2001;21(Suppl.1):S34.
7 Basile C., De Padova F., Giordano R., Montanaro A., De Maio P., Di Marco L., Ligorio V.A., Semeraro A. The incidence of peritonitis declines after implementation of the stay•safe® system (sss). Blood Purification 2001;19:79.